Blood coagulation in immunothrombosis—At the frontline of intravascular immunity

Seminars in Immunology

Volumn 28, Issue 6, 2016, Pages 561-569

  Gaertner, Florian ^a   Massberg, Steffen ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Coagulation; Fibrin; Host defense; Immunothrombosis; Innate immunity; Leukocytes; Platelets

Indexed keywords

FIBRIN; BLOOD CLOTTING FACTOR; PROTEIN BINDING;

BLOOD CLOTTING; DISSEMINATED INTRAVASCULAR CLOTTING; FIBRIN FORMATION; HOST RESISTANCE; HUMAN; INNATE IMMUNITY; LEUKOCYTE; NONHUMAN; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; THROMBOCYTE; THROMBOSIS; ANIMAL; BLOOD; HEMOSTASIS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLISM;

ANIMALS; BLOOD COAGULATION; BLOOD COAGULATION FACTORS; BLOOD PLATELETS; FIBRIN; HEMOSTASIS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; LEUKOCYTES; PROTEIN BINDING; THROMBOSIS;

EID: 85003680946     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2016.10.010     Document Type: Review

References (136)

1. [1] Cines, D.B., Pollak, E.S., Buck, C.A., Loscalzo, J., Zimmerman, G.A., McEver, R.P., Pober, J.S., et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 91:10 (1998), 3527–3561.
2. [2] Dahlbäck, B., Blood coagulation. Lancet 355:9215 (2000), 1627–1632.
3. [3] Bolton-Maggs, P.H.B., Chalmers, E.A., Collins, P.W., Harrison, P., Kitchen, S., Liesner, R.J., Minford, A., et al. A review of inherited platelet disorders with guidelines for their management on behalf of the ukhcdo. Br. J. Haematol. 135:5 (2006), 603–633.
4. [4] Levin, J., Chapter 1 – the evolution of mammalian platelets. Michelson, A.D., (eds.) Platelets (Second Edition), 2007, Academic Press, Burlington, 3–22.
5. [5] Iwanaga, S., The molecular basis of innate immunity in the horseshoe crab. Curr. Opin. Immunol. 14:1 (2002), 87–95.
6. [6] Levin, F., Bang, F., The role of endotoxin in the extracellular coagulation of limulus blood. Bull. Johns Hopkins 115 (1964), 265–274.
7. [7] Coughlin, S.R., Thrombin signalling and protease-activated receptors. Nature 407:6801 (2000), 258–264.
8. [8] Ariki, S., Koori, K., Osaki, T., Motoyama, K., Inamori, K.-i., Kawabata, S.-i., A serine protease zymogen functions as a pattern-recognition receptor for lipopolysaccharides. Proc. Natl. Acad. Sci. U. S. A. 101:4 (2004), 953–958.
9. [9] Muta, T., Iwanaga, S., The role of hemolymph coagulation in innate immunity. Curr. Opin. Immunol. 8:1 (1996), 41–47.
10. [10] Osaki, T., Okino, N., Tokunaga, F., Iwanaga, S., Kawabata, S.-i., Proline-rich cell surface antigens of horseshoe crab hemocytes are substrates for protein cross-linking with a clotting protein coagulin. J. Biol. Chem. 277:42 (2002), 40084–40090.
11. [11] Falati, S., Gross, P., Merrill-Skoloff, G., Furie, B.C., Furie, B., Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse. Nat. Med. 8:10 (2002), 1175–1180.
12. [12] Stetson, C.A., Good, R.A., Studies on the mechanism of the Shwartzman phenomenon: evidence for the participation of polymorphonuclear leucocytes in the phenomenon. J. Exp. Med. 93:1 (1950), 49–64.
13. [13] Niemetz, J., Muhlfelder, T., Chierego, M.E., Troy, B., Procoagulant activity of leukocytes*. Ann. N. Y. Acad. Sci. 283:1 (1977), 208–217.
14. [14] Theopold, U., Schmidt, O., Söderhäll, K., Dushay, M.S., Coagulation in arthropods: defence, wound closure and healing. Trends Immunol. 25:6 (2004), 289–294.
15. [15] Engelmann, B., Massberg, S., Thrombosis as an intravascular effector of innate immunity. Nat. Rev. Immunol. 13:1 (2013), 34–45.
16. [16] Versteeg, H.H., Heemskerk, J.W.M., Levi, M., Reitsma, P.H., New fundamentals in hemostasis. Physiol. Rev. 93:1 (2013), 327–358.
17. [17] Wilcox, J.N., Smith, K.M., Schwartz, S.M., Gordon, D., Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc. Natl. Acad. Sci. U. S. A. 86:8 (1989), 2839–2843.
18. [18] Esmon, C.T., The interactions between inflammation and coagulation. Br. J. Haematol. 131:4 (2005), 417–430.
19. [19] Creasey, A.A., Chang, A.C., Feigen, L., Wün, T.-C., Taylor, J., Hinshaw, F.B.L.B., Tissue factor pathway inhibitor reduces mortality from escherichia coli septic shock. J. Clin. Invest. 91:6 (1993), 2850–2860.
20. [20] Xu, J., Ji, Y., Zhang, X., Drake, M., Esmon, C.T., Endogenous activated protein c signaling is critical to protection of mice from lipopolysaccaride-induced septic shock. J. Thromb. Haemost. 7:5 (2009), 851–856.
21. [21] Yanada, M., Kojima, T., Ishiguro, K., Nakayama, Y., Yamamoto, K., Matsushita, T., Kadomatsu, K., et al. Impact of antithrombin deficiency in thrombogenesis: lipopolysaccharide and stress-induced thrombus formation in heterozygous antithrombin-deficient mice. Blood 99:7 (2002), 2455–2458.
22. [22] Weisel, J.W., Litvinov, R.I., Mechanisms of fibrin polymerization and clinical implications. Blood 121:10 (2013), 1712–1719.
23. [23] Mosesson, M.W., Fibrinogen and fibrin structure and functions. J. Thromb. Haemost. 3:8 (2005), 1894–1904.
24. [24] Prasad, J.M., Gorkun, O.V., Raghu, H., Thornton, S., Mullins, E.S., Palumbo, J.S., Ko, Y.-P., et al. Mice expressing a mutant form of fibrinogen that cannot support fibrin formation exhibit compromised antimicrobial host defense. Blood, 2015.
25. [25] Ryan, E., Mockros, L., Weisel, J., Lorand, L., Structural origins of fibrin clot rheology. Biophys. J. 77:5 (1999), 2813–2826.
26. [26] Undas, A., Ariens, R.A., Fibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic diseases. Arterioscler. Thromb. Vasc. Biol. 31:12 (2011), e88–e99.
27. [27] Blombäck, M., He, S., Bark, N., Wallen, H.N., Elg, M., Effects on fibrin network porosity of anticoagulants with different modes of action and reversal by activated coagulation factor concentrate. Br. J. Haematol. 152:6 (2011), 758–765.
28. [28] Weisel, J.W., Structure of fibrin: impact on clot stability. J. Thromb. Haemost. 5 (2007), 116–124.
29. [29] Ariens, R.A.S., Lai, T.-S., Weisel, J.W., Greenberg, C.S., Grant, P.J., Role of factor xiii in fibrin clot formation and effects of genetic polymorphisms. Blood 100:3 (2002), 743–754.
30. [30] Mutch, N.J., Koikkalainen, J.S., Fraser, S.R., Duthie, K.M., Griffin, M., Mitchell, J., Watson, H.G., et al. Model thrombi formed under flow reveal the role of factor xiii-mediated cross-linking in resistance to fibrinolysis. J. Thromb. Haemost. 8:9 (2010), 2017–2024.
31. [31] Palla, R., Peyvandi, F., Shapiro, A.D., Rare bleeding disorders: diagnosis and treatment. Blood 125:13 (2015), 2052–2061.
32. [32] Loof, T.G., Mörgelin, M., Johansson, L., Oehmcke, S., Olin, A.I., Dickneite, G., Norrby-Teglund, A., et al. Coagulation, an ancestral serine protease cascade, exerts a novel function in early immune defense. Blood 118:9 (2011), 2589–2598.
33. [33] Jen, C.J., McIntire, L.V., The structural properties and contractile force of a clot. Cell Motil. 2:5 (1982), 445–455.
34. [34] Lam, W.A., Chaudhuri, O., Crow, A., Webster, K.D., Li, T.-D., Kita, A., Huang, J., et al. Mechanics and contraction dynamics of single platelets and implications for clot stiffening. Nat. Mater. 10:1 (2011), 61–66.
35. [35] Cines, D.B., Lebedeva, T., Nagaswami, C., Hayes, V., Massefski, W., Litvinov, R.I., Rauova, L., et al. Clot contraction: compression of erythrocytes into tightly packed polyhedra and redistribution of platelets and fibrin. Blood 123:10 (2013), 1596–1603.
36. [36] Aleman, M.M., Byrnes, J.R., Wang, J.-G., Tran, R., Lam, W.A., Di Paola, J., Mackman, N., et al. Factor xiii activity mediates red blood cell retention in venous thrombi. J. Clin. Invest. 124:8 (2014), 3590–3600.
37. [37] Byrnes, J.R., Duval, C., Wang, Y., Hansen, C.E., Ahn, B., Mooberry, M.J., Clark, M.A., et al. Factor xiiia-dependent retention of red blood cells in clots is mediated by fibrin Î ± −chain crosslinking. Blood 126:16 (2015), 1940–1948.
38. [38] Aleman, M.M., Walton, B.L., Byrnes, J.R., Wolberg, A.S., Fibrinogen and red blood cells in venous thrombosis. Thromb. Res. 133:0 1 (2014), S38–S40.
39. [39] Whelihan, M.F., Zachary, V., Orfeo, T., Mann, K.G., Prothrombin activation in blood coagulation: the erythrocyte contribution to thrombin generation. Blood 120:18 (2012), 3837–3845.
40. [40] Wohner, N., Sotonyi, P., Machovich, R., Szabo, L., Tenekedjiev, K., Silva, M.M., Longstaff, C., et al. Lytic resistance of fibrin containing red blood cells. Arterioscler. Thromb. Vasc. Biol. 31:10 (2011), 2306–2313.
41. [41] Morera, D., MacKenzie, S.A., Is there a direct role for erythrocytes in the immune response?. Vet. Res., 42(1), 2011, 89.
42. [42] Baum, J., Ward, R.H., Conway, D.J., Natural selection on the erythrocyte surface. Mol. Biol. Evol. 19:3 (2002), 223–229.
43. [43] Gagneux, P., Varki, A., Evolutionary considerations in relating oligosaccharide diversity to biological function. Glycobiology 9:8 (1999), 747–755.
44. [44] Liu, J., Tan, Y., Zhang, H., Zhang, Y., Xu, P., Chen, J., Poh, Y.-C., et al. Soft fibrin gels promote selection and growth of tumorigenic cells. Nat. Mater. 11:8 (2012), 734–741.
45. [45] Rouillard, A., Holmes, J.W., Mechanical boundary conditions bias fibroblast invasion in a collagen-fibrin wound model. Biophys. J. 106:4 (2014), 932–943.
46. [46] Massberg Grahl, S.L., von Bruehl, M.-L., Manukyan, D., Pfeiler, S., Goosmann, C., Brinkmann, V., et al. Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. Nat. Med. 16:8 (2010), 887–896.
47. [47] Guggenberger, C., Wolz, C., Morrissey, J.A., Heesemann, J., Two distinct coagulase-dependent barriers protect staphylococcus aureus from neutrophils in a three dimensional in vitro infection model. PLoS Pathog., 8(1), 2012, e1002434.
48. [48] Stalker, T.J., Welsh, J.D., Tomaiuolo, M., Wu, J., Colace, T.V., Diamond, S.L., Brass, L.F., A systems approach to hemostasis: 3. thrombus consolidation regulates intrathrombus solute transport and local thrombin activity. Blood 124:11 (2014), 1824–1831.
49. [49] Semple, J.W., Italiano, J.E., Freedman, J., Platelets and the immune continuum. Nat. Rev. Immunol. 11:4 (2011), 264–274.
50. [50] Cox, D., Kerrigan, S.W., Watson, S.P., Platelets and the innate immune system: mechanisms of bacterial-induced platelet activation. J. Thromb. Haemost. 9:6 (2011), 1097–1107.
51. [51] Levy, O., Antimicrobial proteins and peptides of blood: templates for novel antimicrobial agents. Blood 96:8 (2000), 2664–2672.
52. [52] Denis, C.V., Wagner, D.D., Platelet adhesion receptors and their ligands in mouse models of thrombosis. Arterioscler. Thromb. Vasc. Biol. 27:4 (2007), 728–739.
53. [53] Lentz, B.R., Exposure of platelet membrane phosphatidylserine regulates blood coagulation. Prog. Lipid Res. 42:5 (2003), 423–438.
54. [54] Morrissey, J.H., Choi, S.H., Smith, S.A., Polyphosphate: an ancient molecule that links platelets, coagulation, and inflammation. Blood 119:25 (2012), 5972–5979.
55. [55] Smith, S.A., Mutch, N.J., Baskar, D., Rohloff, P., Docampo, R., Morrissey, J.H., Polyphosphate modulates blood coagulation and fibrinolysis. Proc. Natl. Acad. Sci. U. S. A. 103:4 (2006), 903–908.
56. [56] Müller, F., Mutch, N.J., Schenk, W.A., Smith, S.A., Esterl, L., Spronk, H.M., Schmidbauer, S., et al. Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo. Cell 139:6 (2009), 1143–1156.
57. [57] Frick, I.-M., Akesson, P., Herwald, H., Mörgelin, M., Malmsten, M., Nägler, D.K., Björck, L., The contact system–a novel branch of innate immunity generating antibacterial peptides. The EMBO Journal 25:23 (2006), 5569–5578.
58. [58] Niewiarowski, S., Rogoeczi, E., Steward, G.J., Senyi, A.F., Mustard, J.F., Platelet interaction with polymerizing fibrin. J. Clin. Invest. 51:3 (1972), 685–700.
59. [59] Hantgan, R., Hindriks, G., Taylor, R., Sixma, J., de Groot, P., Glycoprotein ib, von willebrand factor, and glycoprotein iib:iiia are all involved in platelet adhesion to fibrin in flowing whole blood. Blood 76:2 (1990), 345–353.
60. [60] Li, Z., Delaney, M.K., O'Brien, K.A., Du, X., Signaling during platelet adhesion and activation. Arterioscler. Thromb. Vasc. Biol. 30:12 (2010), 2341–2349.
61. [61] Qiu, Y., Brown, A.C., Myers, D.R., Sakurai, Y., Mannino, R.G., Tran, R., Ahn, B., et al. Platelet mechanosensing of substrate stiffness during clot formation mediates adhesion, spreading, and activation. Proc. Natl. Acad. Sci. 111:40 (2014), 14430–14435.
62. [62] Massberg, S., Gawaz, M., Grüner, S., Schulte, V., Konrad, I., Zohlnhöfer, D., Heinzmann, U., et al. A crucial role of glycoprotein vi for platelet recruitment to the injured arterial wall in vivo. J. Exp. Med. 197:1 (2002), 41–49.
63. [63] Nieswandt, B., Schulte, V., Bergmeier, W., Mokhtari-Nejad, R., Rackebrandt, K., Cazenave, J.-P., Ohlmann, P., et al. Long-term antithrombotic protection by in vivo depletion of platelet glycoprotein vi in mice. J. Exp. Med. 193:4 (2001), 459–470.
64. [64] Mammadova-Bach, E., Ollivier, V., Loyau, S., Schaff, M., Dumont, B., Favier, R., Freyburger, G., et al. Platelet glycoprotein vi binds to polymerized fibrin and promotes thrombin generation. Blood 126:5 (2015), 683–691.
65. [65] Peerschke, E.I., Yin, W., Ghebrehiwet, B., Complement activation on platelets: implications for vascular inflammation and thrombosis. Mol. Immunol. 47:13 (2010), 2170–2175.
66. [66] Silasi-Mansat, R., Zhu, H., Popescu, N.I., Peer, G., Sfyroera, G., Magotti, P., Ivanciu, L., et al. Complement inhibition decreases the procoagulant response and confers organ protection in a baboon model of escherichia coli sepsis. Blood 116:6 (2010), 1002–1010.
67. [67] Verschoor, A., Neuenhahn, M., Navarini, A.A., Graef, P., Plaumann, A., Seidlmeier, A., Nieswandt, B., et al., A platelet-mediated system for shuttling blood-borne bacteria to cd8[alpha]+ dendritic cells depends on glycoprotein gpib and complement c3. Nat. Immunol. 12:12 (2011), 1194–1201.
68. [68] Guidotti, L., Inverso, D., Sironi, L., Di Lucia, P., Fioravanti, J., Ganzer, L., Fiocchi, A., et al. Immunosurveillance of the liver by intravascular effector cd8+ t cells. Cell 161:3 (2015), 486–500.
69. [69] Kastrup, C.J., Boedicker, J.Q., Pomerantsev, A.P., Moayeri, M., Bian, Y., Pompano, R.R., Kline, T.R., et al. Spatial localization of bacteria controls coagulation of human blood by ’quorum acting’. Nat. Chem. Biol. 4:12 (2008), 742–750.
70. [70] Kraemer, B.F., Campbell, R.A., Schwertz, H., Cody, M.J., Franks, Z., Tolley, N.D., Kahr, W.H.A., et al. Novel anti-bacterial activities of ß-defensin 1 in human platelets: suppression of pathogen growth and signaling of neutrophil extracellular trap formation. PLoS Pathog., 7(11), 2011, e1002355.
71. [71] Tapper, H., Herwald, H., Modulation of hemostatic mechanisms in bacterial infectious diseases. Blood 96:7 (2000), 2329–2337.
72. [72] Yeaman, M.R., Platelets: at the nexus of antimicrobial defence. Nat Rev Micro 12:6 (2014), 426–437.
73. [73] Fitzgerald, J.R., Foster, T.J., Cox, D., The interaction of bacterial pathogens with platelets. Nat Rev Micro 4:6 (2006), 445–457.
74. [74] Thammavongsa, V., Kim, H.K., Missiakas, D., Schneewind, O., Staphylococcal manipulation of host immune responses. Nat. Rev. Microbiol. 13:9 (2015), 529–543.
75. [75] Wu, T., Yeaman, M.R., Bayer, A.S., In vitro resistance to platelet microbicidal protein correlates with endocarditis source among bacteremic staphylococcal and streptococcal isolates. Antimicrob. Agents Chemother. 38:4 (1994), 729–732.
76. [76] Peschel, A., Jack, R.W., Otto, M., Collins, L.V., Staubitz, P., Nicholson, G., Kalbacher, H., et al. Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor mprf is based on modification of membrane lipids with l-lysine. J. Exp. Med. 193:9 (2001), 1067–1076.
77. [77] Cheng, A.G., McAdow, M., Kim, H.K., Bae, T., Missiakas, D.M., Schneewind, O., Contribution of coagulases towards Staphylococcus aureus disease and protective immunity. PLoS Pathog., 6(8), 2010, e1001036.
78. [78] Weber, C., Noels, H., Atherosclerosis: current pathogenesis and therapeutic options. Nat. Med. 17:11 (2011), 1410–1422.
79. [79] Haselmayer, P., Grosse-Hovest, L., v. Landenberg, P., Schild, H., Radsak, M.P., Trem −1 ligand expression on platelets enhances neutrophil activation. Blood, 2007.
80. [80] van Gils, J.M., da Costa Martins, P.A., Mol, A., Hordijk, P.L., Zwaginga, J.J., Transendothelial migration drives dissociation of plateletmonocyte complexes. Thromb. Haemost. 100:8 (2008), 271–279.
81. [81] Sreeramkumar, V., Adrover, J.M., Ballesteros, I., Cuartero, M.I., Rossaint, J., Bilbao, I., Nacher, M., et al. Neutrophils scan for activated platelets to initiate inflammation. Science (New York, N.Y.) 346:6214 (2014), 1234–1238.
82. [82] Etulain, J., Martinod, K., Wong, S.L., Cifuni, S.M., Schattner, M., Wagner, D.D., P-selectin promotes neutrophil extracellular trap formation in mice. Blood 126:2 (2015), 242–246.
83. [83] Brinkmann, V., Reichard, U., Goosmann, C., Fauler, B., Uhlemann, Y., Weiss, D.S., Weinrauch, Y., et al. Neutrophil extracellular traps kill bacteria. Science 303:5663 (2004), 1532–1535.
84. [84] Xu, J., Zhang, X., Pelayo, R., Monestier, M., Ammollo, C.T., Semeraro, F., Taylor, F.B., et al. Extracellular histones are major mediators of death in sepsis. Nat. Med. 15:11 (2009), 1318–1321.
85. [85] Semeraro, F., Ammollo, C.T., Morrissey, J.H., Dale, G.L., Friese, P., Esmon, N.L., Esmon, C.T., Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet tlr2 and tlr4. Blood 118:7 (2011), 1952–1961.
86. [86] Fuchs, T.A., Brill, A., Duerschmied, D., Schatzberg, D., Monestier, M., Myers, D.D., Wrobleski, S.K., et al. Extracellular dna traps promote thrombosis. Proc. Natl. Acad. Sci. 107:36 (2010), 15880–15885.
87. [87] Xu, J., Zhang, X., Monestier, M., Esmon, N.L., Esmon, C.T., Extracellular histones are mediators of death through tlr2 and tlr4 in mouse fatal liver injury. J. Immunol. 187:5 (2011), 2626–2631.
88. [88] Gould, T.J., Vu, T.T., Swystun, L.L., Dwivedi, D.J., Mai, S.H., Weitz, J.I., Liaw, P.C., Neutrophil extracellular traps promote thrombin generation through platelet-dependent and platelet-independent mechanisms. Arterioscler. Thromb. Vasc. Biol. 34:9 (2014), 1977–1984.
89. [89] von Brühl, M.-L., Stark, K., Steinhart, A., Chandraratne, S., Konrad, I., Lorenz, M., Khandoga, A., et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J. Exp. Med. 209:4 (2012), 819–835.
90. [90] Darbousset, R., Thomas, G.M., Mezouar, S., Frere, C., Bonier, R., Mackman, N., Renne, T., et al. Tissue factor-positive neutrophils bind to injured endothelial wall and initiate thrombus formation. Blood 120:10 (2012), 2133–2143.
91. [91] Kaplan, Z.S., Zarpellon, A., Alwis, I., Yuan, Y., McFadyen, J., Ghasemzadeh, M., Schoenwaelder, S.M., et al. Thrombin-dependent intravascular leukocyte trafficking regulated by fibrin and the platelet receptors gpib and par4. Nat. Commun., 6, 2015.
92. [92] Loike, J.D., el Khoury, J., Cao, L., Richards, C.P., Rascoff, H., Mandeville, J.T., Maxfield, F.R., et al. Fibrin regulates neutrophil migration in response to interleukin 8, leukotriene b4, tumor necrosis factor, and formyl-methionyl-leucyl-phenylalanine. J. Exp. Med. 181:5 (1995), 1763–1772.
93. [93] Flick, M.J., Du, X., Witte, D.P., Jirouskova, M., Soloviev, D.A., Busuttil, S.J., Plow, E.F., et al. Leukocyte engagement of fibrin(ogen) via the integrin receptor alpha m beta 2/mac-1 is critical for host inflammatory response in vivo. J. Clin. Invest. 113:11 (2004), 1596–1606.
94. [94] Lammermann, T., Bader, B.L., Monkley, S.J., Worbs, T., Wedlich-Soldner, R., Hirsch, K., Keller, M., et al. Rapid leukocyte migration by integrin-independent flowing and squeezing. Nature 453:7191 (2008), 51–55.
95. [95] Maugeri, N., Brambilla, M., Camera, M., Carbone, A., Tremoli, E., Donati, M.B., de Gaetano, G., et al. Human polymorphonuclear leukocytes produce and express functional tissue factor upon stimulation1. J. Thromb. Haemost. 4:6 (2006), 1323–1330.
96. [96] Moosbauer, C., Morgenstern, E., Cuvelier, S.L., Manukyan, D., Bidzhekov, K., Albrecht, S., Lohse, P., et al. Eosinophils are a major intravascular location for tissue factor storage and exposure. Blood 109:3 (2006), 995–1002.
97. [97] Rivers, R.P.A., Hathaway, W.E., Weston, W.L., The endotoxin-induced coagulant activity of human monocytes. Br. J. Haematol. 30:3 (1975), 311–316.
98. [98] Müller, I., Klocke, A., Alex, M., Kotzsch, M., Luther, T., Morgenstern, E., Zieseniss, S., et al. Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets. The FASEB J., 2003.
99. [99] Giesen, P.L.A., Rauch, U., Bohrmann, B., Kling, D., Roque, M., Fallon, J.T., Badimon, J.J., et al. Blood-borne tissue factor: another view of thrombosis. Proc. Natl. Acad. Sci. 96:5 (1999), 2311–2315.
100. [100] Furie, B., Flaumenhaft, R., Thiol isomerases in thrombus formation. Circ. Res. 114:7 (2014), 1162–1173.
101. [101] Reinhardt, C., von Brühl, M.-L., Manukyan, D., Grahl, L., Lorenz, M., Altmann, B., Dlugai, S., et al. Protein disulfide isomerase acts as an injury response signal that enhances fibrin generation via tissue factor activation. J. Clin. Invest. 118:3 (2007), 1110–1122.
102. [102] Jasuja, R., Passam, F.H., Kennedy, D.R., Kim, S.H., van Hessem, L., Lin, L., Bowley, S.R., et al. Protein disulfide isomerase inhibitors constitute a new class of antithrombotic agents. J. Clin. Invest. 122:6 (2012), 2104–2113.
103. [103] Cho, J., Furie, B.C., Coughlin, S.R., Furie, B., A critical role for extracellular protein disulfide isomerase during thrombus formation in mice. J. Clin. Invest. 118:3 (2008), 1123–1131.
104. [104] Schulz, C., Engelmann, B., Massberg, S., Crossroads of coagulation and innate immunity: the case of deep vein thrombosis. J. Thromb. Haemost. 11 (2013), 233–241.
105. [105] Takano, S., Kimura, S., Ohdama, S., Aoki, N., Plasma thrombomodulin in health and diseases. Blood 76:10 (1990), 2024–2029.
106. [106] Glaser, C.B., Morser, J., Clarke, J.H., Blasko, E., McLean, K., Kuhn, I., Chang, R.J., et al. Oxidation of a specific methionine in thrombomodulin by activated neutrophil products blocks cofactor activity. a potential rapid mechanism for modulation of coagulation. J. Clin. Invest. 90:6 (1992), 2565–2573.
107. [107] Jaillon, S., Peri, G., Delneste, Y., Fremaux, I., Doni, A., Moalli, F., Garlanda, C., et al. The humoral pattern recognition receptor ptx3 is stored in neutrophil granules and localizes in extracellular traps. J. Exp. Med. 204:4 (2007), 793–804.
108. [108] Cho, J.H., Fraser, I.P., Fukase, K., Kusumoto, S., Fujimoto, Y., Stahl, G.L., Ezekowitz, R.A.B., Human peptidoglycan recognition protein s is an effector of neutrophil-mediated innate immunity. Blood 106:7 (2005), 2551–2558.
109. [109] Dziarski, R., Platt, K.A., Gelius, E., Steiner, H., Gupta, D., Defect in neutrophil killing and increased susceptibility to infection with nonpathogenic gram-positive bacteria in peptidoglycan recognition protein-s (pgrp-s)-deficient mice. Blood 102:2 (2003), 689–697.
110. [110] Kolaczkowska, E., Jenne, C.N., Surewaard, B.G.J., Thanabalasuriar, A., Lee, W.-Y., Sanz, M.-J., Mowen, K., et al. Molecular mechanisms of net formation and degradation revealed by intravital imaging in the liver vasculature. Nat. Commun., 6, 2015.
111. [111] Grässle, S., Huck, V., Pappelbaum, K.I., Gorzelanny, C., Aponte-Santamaria, C., Baldauf, C., Gräter, F., et al. von willebrand factor directly interacts with dna from neutrophil extracellular traps. Arterioscler. Thromb. Vasc. Biol. 34:7 (2014), 1382–1389.
112. [112] Wong, C.H.Y., Jenne, C.N., Petri, B., Chrobok, N.L., Kubes, P., Nucleation of platelets with blood-borne pathogens on kupffer cells precedes other innate immunity and contributes to bacterial clearance. Nat. Immunol. 14:8 (2013), 785–792.
113. [113] Kolaczkowska, E., Jenne, C.N., Surewaard, B.G.J., Thanabalasuriar, A., Lee, W.-Y., Sanz, M.-J., Mowen, K., et al. Molecular mechanisms of net formation and degradation revealed by intravital imaging in the liver vasculature. Nat. Commun., 6, 2015, 6673.
114. [114] Longstaff, C., Varju, I., Sotonyi, P., Szabo, L., Krumrey, M., Hoell, A., Bota, A., et al. Mechanical stability and fibrinolytic resistance of clots containing fibrin, dna, and histones. J. Biol. Chem. 288:10 (2013), 6946–6956.
115. [115] Angus, D.C., van der Poll, T., Severe sepsis and septic shock. N. Engl. J. Med. 369:9 (2013), 840–851.
116. [116] Pawlinski, R., Pedersen, B., Schabbauer, G., Tencati, M., Holscher, T., Boisvert, W., Andrade-Gordon, P., et al. Role of tissue factor and protease-activated receptors in a mouse model of endotoxemia. Blood 103:4 (2003), 1342–1347.
117. [117] Pawlinski, R., Wang, J.-G., Owens, A.P., Williams, J., Antoniak, S., Tencati, M., Luther, T., et al. Hematopoietic and nonhematopoietic cell tissue factor activates the coagulation cascade in endotoxemic mice. Blood 116:5 (2010), 806–814.
118. [118] Luo, D., Szaba, F.M., Kummer, L.W., Plow, E.F., Mackman, N., Gailani, D., Smiley, S.T., Protective roles for fibrin, tissue factor, plasminogen activator inhibitor-1, and thrombin activatable fibrinolysis inhibitor, but not factor xi, during defense against the gram-negative bacterium yersinia enterocolitica. J. Immunol. 187:4 (2011), 1866–1876.
119. [119] Beiter, K., Wartha, F., Albiger, B., Normark, S., Zychlinsky, A., Henriques-Normark, B., An endonuclease allows streptococcus pneumoniae to escape from neutrophil extracellular traps. Curr. Biol. 16:4 (2006), 401–407.
120. [120] Walker, M.J., Hollands, A., Sanderson-Smith, M.L., Cole, J.N., Kirk, J.K., Henningham, A., McArthur, J.D., et al. Dnase sda1 provides selection pressure for a switch to invasive group a streptococcal infection. Nat. Med. 13:8 (2007), 981–985.
121. [121] McDonald, B., Urrutia, R., Yipp, B., Jenne, C., Kubes, P., Intravascular neutrophil extracellular traps capture bacteria from the bloodstream during sepsis. Cell Host Microb. 12:3 (2012), 324–333.
122. [122] Clark, S.R., Ma, A.C., Tavener, S.A., McDonald, B., Goodarzi, Z., Kelly, M.M., Patel, K.D., et al. Platelet tlr4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat. Med. 13:4 (2007), 463–469.
123. [123] Levi, M., Toh, C.H., Thachil, J., Watson, H.G., Guidelines for the diagnosis and management of disseminated intravascular coagulation. Br. J. Haematol. 145:1 (2009), 24–33.
124. [124] Libby, P., Simon, D.I., Inflammation and thrombosis. The clot thickens. Circulation 103:13 (2001), 1718–1720.
125. [125] Riegger, J., Byrne, R.A., Joner, M., Chandraratne, S., Gershlick, A.H., ten Berg, J.M., Adriaenssens, T., et al. Histopathological evaluation of thrombus in patients presenting with stent thrombosis. a multicenter european study: a report of the prevention of late stent thrombosis by an interdisciplinary global european effort consortium. Eur. Heart J., 2015.
126. [126] Jackson, S.P., Arterial thrombosis − insidious, unpredictable and deadly. Nat. Med. 17:11 (2011), 1423–1436.
127. [127] Falk, E., Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis. characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. Br. Heart J. 50:2 (1983), 127–134.
128. [128] Libby, P., Inflammation in atherosclerosis. Nature 420:6917 (2002), 868–874.
129. [129] Ruggeri, Z.M., Platelets in atherothrombosis. Nat. Med. 8:11 (2002), 1227–1234.
130. [130] Palabrica, T., Lobb, R., Furie, B.C., Aronovitz, M., Benjamin, C., Hsu, Y.-M., Sajer, S.A., et al. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by p-selectin on adherent platelets. Nature 359:6398 (1992), 848–851.
131. [131] Falati, S., Liu, Q., Gross, P., Merrill-Skoloff, G., Chou, J., Vandendries, E., Celi, A., et al. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle p-selectin glycoprotein ligand 1 and platelet p-selectin. J. Exp. Med. 197:11 (2003), 1585–1598.
132. [132] Chou, J., Mackman, N., Merrill-Skoloff, G., Pedersen, B., Furie, B.C., Furie, B., Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation. Blood 104:10 (2004), 3190–3197.
133. [133] Renne, T., Pozgajova, C.M., Grüner, S., Schuh, K., Pauer, H.-U., Burfeind, P., Gailani, D., et al. Defective thrombus formation in mice lacking coagulation factor xii. J. Exp. Med. 202:2 (2005), 271–281.
134. [134] Kleinschnitz, C., Stoll, G., Bendszus, M., Schuh, K., Pauer, H.-U., Burfeind, P., Renne, C., et al. Targeting coagulation factor xii provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis. J. Exp. Med. 203:3 (2006), 513–518.
135. [135] Warnatsch, A., Ioannou, M., Wang, Q., Papayannopoulos, V., Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis. Science 349:6245 (2015), 316–320.
136. [136] Mangold, A., Alias, S., Scherz, T., Hofbauer, T., Jakowitsch, J., Panzenboeck, A., Simon, D., et al. Coronary neutrophil extracellular trap burden and dnase activity in st-elevation acute coronary syndrome are predictors of st-segment resolution and infarct size. Circ. Res., 2014.